Scheme representing the oxylipins (a), and the endocannabinoids, N-acylethanolamines, and fatty acid glycerol esters (b) that were analyzed (in filled squares), with their enzymatic pathways. Detected metabolites in lung lavage fluids are highlighted in bold. Abbreviations: COX—cyclooxygenase, LOX—lipoxygenase, CYP—cytochrome P450, FAAH—fatty acid amide hydrolase, MAGL—monoacylglycerol lipase. Compounds from the COX pathway included prostaglandins (PGD2, PGE2, PGF2α, and 6-ketoPGF1α) and thromboxane (TXB2). The LOX pathway metabolites included hydroxyeicosatetraenoic acids (HETEs), hydroxyeicosapentaenoic acids (HEPEs), leukotrienes (LTB4), oxoeicosatetraenoic acids (oxo-ETEs), hydroxyeicosatrienoic acids (HETrEs), oxooctadecadienoic acid (oxo-ODEs), hydroxyoctadecadienoic acids (HODEs), and trihydroxyoctadecenoic acids (TriHOMEs). The CYP pathway included epoxyeicosatrienoic acids (EETs), epoxyoctadecenoic acids (EpOMEs), dihydroxyoctadecenoic acids (DiHOMEs), and dihydroxyeicosatrienoic acids (DHETs). Endocannabinoids, N-acylethanolamines, and fatty acid glycerol esters included the following: 2-linoleoylglycerol (2-LG), 2-arachidonoylglycerol (2-AG), N-arachidonylglycine (NAGly), stearoyl ethanolamide (SEA), docosatetraenyl ethanolamide (DEA), palmitoleoyl ethanolamide (POEA), palmitoyl ethanolamide (PEA), docosahexaenoyl ethanolamide (DHEA), eicosapentaenoyl ethanolamide (EPEA), oleoyl ethanolamide (OEA), linoleoyl ethanolamide (LEA), arachidonoyl ethanolamide (AEA), prostaglandin F2α ethanolamide (PGF
2α
-EA), and prostaglandin E2 ethanolamide (PGE
2
-EA)